Динамика изменений иммунофенотипа В-лимфоцитов на различных стадиях хронического лимфолейкоза, их диагностическое и прогностическое значения
Т Н Жевак, Н. П. Чеснокова, Т. В. Шелехова, М. Н. Бизенкова, О. Е. Царева
Abstract
Т Н Жевак, Н. П. Чеснокова, Т. В. Шелехова, М. Н. Бизенкова, О. Е. Царева
Abstract
The research work presents results of clinical laboratory investigations of dynamic changes of immune phenotype of B-lymphocytes in different stages of B-cell mode of chronic lymphocytic leukemia. The detection of the content of CD-marker molecules in 60 patients with different stages of B-cell mode of chronic lymphocytic leukemia (0-I, II, III, IV according K.R. Rai et al. classification, 1975) was conducted. Investigation of the character of expression of marker molecules (CD19, CD5, CD20, CD23, CD38) on B-lymphocytes of peripheral blood with using of standard panel of monoclonal antibodies for flow cytometry «Facs-Calibur» (BD, USA, 2006) was carried out. The examination of patients with this pathology reveals some regularities of changes of immune phenotype of B-lymphocytes which were parallel with stages of the disease. The appearance of atypia of B-lymphocytes characterized by co-expression of CD19 and CD5 as well as significant activation of B-cells characterized by expression of CD23 and CD38 were observed.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The research work presents results of clinical laboratory investigations of dynamic changes of immune phenotype of B-lymphocytes in different stages of B-cell mode of chronic lymphocytic leukemia. The detection of the content of CD-marker molecules in 60 patients with different stages of B-cell mode of chronic lymphocytic leukemia (0-I, II, III, IV according K.R. Rai et al. classification, 1975) was conducted. Investigation of the character of expression of marker molecules (CD19, CD5, CD20, CD23, CD38) on B-lymphocytes of peripheral blood with using of standard panel of monoclonal antibodies for flow cytometry «Facs-Calibur» (BD, USA, 2006) was carried out. The examination of patients with this pathology reveals some regularities of changes of immune phenotype of B-lymphocytes which were parallel with stages of the disease. The appearance of atypia of B-lymphocytes characterized by co-expression of CD19 and CD5 as well as significant activation of B-cells characterized by expression of CD23 and CD38 were observed.
Key concepts: CD5, CD19, CD23, CD20, CD38, Chronic lymphocytic leukemia, Flow cytometry, Immunophenotyping